Charles Sang
Keine laufenden Positionen mehr
Profil
Charles Sang worked as a Marketing Director at Seagen Inc. from 2010 to 2012.
He then worked as Vice President-Global Diagnostics at NanoString Technologies, Inc. from 2012 to 2016.
From 2016 to 2020, he worked as Senior Vice President-Clinical Diagnostics at Adaptive Biotechnologies Corp.
Mr. Sang completed his undergraduate degree at National-Louis University and his graduate degree at New Mexico State University.
Ehemalige bekannte Positionen von Charles Sang
| Unternehmen | Position | Ende |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Corporate Officer/Principal | 09.04.2020 |
| NANOSTRING TECHNOLOGIES, INC. | Corporate Officer/Principal | 01.04.2016 |
| SEAGEN INC. | Vertrieb & Marketing | 01.11.2012 |
Ausbildung von Charles Sang
| National-Louis University | Undergraduate Degree |
| New Mexico State University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
